Lastacaft 0.25 % Ophthalmic Solution
- RxCUI
- 1000089
- RxNorm name
- Lastacaft 0.25 % Ophthalmic Solution
- Display name
- Lastacaft 0.25 % Ophthalmic Solution
- Full name
- Lastacaft 0.25 % Ophthalmic Solution
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:48
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| LASTACAFT | ALCAFTADINE | Allergan, Inc. | a3002410-4bf1-4182-9d7c-8193eb7cd215 | 2022-08-10 | Warnings | 1000089 |
| LASTACAFT | ALCAFTADINE | Allergan, Inc. | 17d37e8d-7825-424b-b6ca-0a85d0bf4694 | 2020-06-01 | Warnings, Adverse reactions | 1000089 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 17d37e8d-7825-424b-b6ca-0a85d0bf4694 | LASTACAFT 0.25 % Ophthalmic Solution [PSN] · alcaftadine 2.5 MG/ML Ophthalmic Solution [Lastacaft] [SBD] · Lastacaft 0.25 % Ophthalmic Solution [SY] · Lastacaft 2.5 MG/ML Ophthalmic Solution [SY] | 4 | 21 | These highlights do not include all the information needed to use LASTACAFT ® safely and effectively. See full prescribing information for LASTACAFT ® . LASTACAFT ® (alcaftadine ophthalmic solution) , f or t opical o phthalmic u se Initial U.S. Approval: 2010 | 20200601 |
| a3002410-4bf1-4182-9d7c-8193eb7cd215 | LASTACAFT 0.25 % Ophthalmic Solution [PSN] · alcaftadine 2.5 MG/ML Ophthalmic Solution [Lastacaft] [SBD] · Lastacaft 0.25 % Ophthalmic Solution [SY] · Lastacaft 2.5 MG/ML Ophthalmic Solution [SY] | 4 | 4 | LASTACAFT ® Antihistamine Eye Drops Drug Facts | 20220810 |
| 4b8c6afe-2d76-46c7-a23e-99db5e180ff6 | LASTACAFT 0.25 % Ophthalmic Solution [PSN] · alcaftadine 2.5 MG/ML Ophthalmic Solution [Lastacaft] [SBD] · Lastacaft 0.25 % Ophthalmic Solution [SY] · Lastacaft 2.5 MG/ML Ophthalmic Solution [SY] | 4 | 1 | These highlights do not include all the information needed to use LASTACAFT ® safely and effectively. See full prescribing information for LASTACAFT ® . LASTACAFT ® (alcaftadine ophthalmic solution) 0.25% Initial U.S. Approval: 2010 | 20120905 |
| c192fecc-046d-4905-868f-b8200320309c | LASTACAFT 0.25 % Ophthalmic Solution [PSN] · alcaftadine 2.5 MG/ML Ophthalmic Solution [Lastacaft] [SBD] · Lastacaft 0.25 % Ophthalmic Solution [SY] · Lastacaft 2.5 MG/ML Ophthalmic Solution [SY] | 4 | 1 | These highlights do not include all the information needed to use LASTACAFT™ safely and effectively. See full prescribing information for LASTACAFT™. LASTACAFT™ (alcaftadine ophthalmic solution) 0.25% Initial U.S. Approval: 2010 | 20100930 |